دانلود کتاب تشخیص و شناسایی سرطان، کتابچه راهنمای فناوری‌های نوظهور

This is the second edition of Biosensors and Molecular Technologies for Cancer Diagnosis, initially published in 2012 by CRC Press. Since the first edition, many new cancer technologies have been developed, which have been included to broaden the book’s scope beyond biosensors. This second edition is entitled Cancer Detection and Diagnosis: A Handbook of Emerging Technologies. Cancer is a major global health concern. In 2022, there were approximately 20 million new cancer cases and 9.7 million cancer-related deaths worldwide. Early cancer detection and accurate diagnoses are essential for effective treatment, and addressing cancer challenges requires improving cancer detection and diagnosis, a need that is a well-recognized imperative. Research on new cancer technologies has expanded in recent years, and many new technologies have been published in various publications, describing novel biomedical and analytical applications for cancer detection and diagnosis. However, despite their potential, many of these technologies are absent today in clinical cancer settings. To support the development of cancer technologies, this book describes novel experimental approaches and their potential applications to cancer detection, diagnosis, and treatment, which may help to facilitate their utilization and integration into future medical practice. Six bioengineering analytical approaches are described in this book: (i) Optical, (ii) imaging, (iii) nucleic acid, (iv) biomarker and molecular, (v) organelle and cellular, and (vi) computational/digital technologies. Some potential readers of this technology-oriented book may not be very familiar with cancer challenges and complexities, or the terminology used in the book; for these readers we included a section on the basic elements of cancer. The book is designed to make these technologies more accessible and understandable to molecular biologists, oncologists, pathologists, engineers, and students. The development of many of the technologies described in this book was supported by the US National Cancer Institute (NCI). We hope the book will help bridge the gap between emerging cancer technologies and basic and clinical cancer research by providing concise and detailed technical information on these technologies, which may help to bring new biomedical technologies to cancer patients.